Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by <i>Mycobacterium avium</i> Complex (CONVERT). A Prospective, Open-Label, Randomized StudyDavid E. Griffith, Kevin Winthrop, Naoki Hasegawa et al.|American Journal of Respiratory and Critical Care Medicine|2018Cited by 343
Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung DiseaseDavid E. Griffith, Kevin Winthrop, Rachel Thomson et al.|CHEST Journal|2021Cited by 52